Mercer Global Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Mercer Global Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$490K	Sell	5,652 -2,556	-31%	-$224K	﹤0.01%	1999
2025 Q4	$696K	Sell	8,208 -103	-1%	-$8.22K	﹤0.01%	1659
2025 Q3	$603K	Buy	8,311 +4,446	+115%	+$307K	﹤0.01%	1654
2025 Q2	$253K	Sell	3,865 -121	-3%	-$7.88K	﹤0.01%	1948
2025 Q1	$281K	Sell	3,986 -25	-0.6%	-$1.74K	﹤0.01%	1795
2024 Q4	$264K	Buy	4,011 +21	+0.5%	+$1.45K	﹤0.01%	1824
2024 Q3	$281K	Buy	3,990 +153	+4%	+$10.7K	﹤0.01%	1647
2024 Q2	$254K	Buy	3,837 +266	+7%	+$17.4K	﹤0.01%	1668
2024 Q1	$242K	Buy	+3,571	New	+$236K	﹤0.01%	1682
2023 Q2	–	Sell	-4,419	Closed	-$258K	–	1979
2023 Q1	$258K	Buy	+4,419	New	+$266K	﹤0.01%	1594

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Mercer Global Advisors's IHE Position: Q1 2026 in Review

Mercer Global Advisors reduced its iShares US Pharmaceuticals ETF (IHE) stake by 31% in Q1 2026, selling an estimated $224K and leaving 5,652 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #1999.

Mercer Global Advisors first reported a position in IHE in Q1 2023 and has held it in 10 quarters since. The position peaked at $696K in Q4 2025. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

Mercer Global Advisors held 5,652 shares of iShares US Pharmaceuticals ETF worth $490K as of Q1 2026.
Mercer Global Advisors sold 2,556 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $224K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #1999 holding.
Mercer Global Advisors first reported a position in iShares US Pharmaceuticals ETF in Q1 2023 and has held it in 10 quarters since.
Mercer Global Advisors's iShares US Pharmaceuticals ETF position peaked at $696K in Q4 2025.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.